SHANGHAI and HONOLULU, Aug. 10,
2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE:
WX), a leading open-access R&D capability and technology
platform company serving the pharmaceutical, biotechnology, and
medical device industries, and TruTag Technologies, Inc., developer
of an innovative edible security platform for pharmaceuticals,
today announced the successful completion of joint testing of
TruTag's on-dose authentication solution.
TruTags offer a unique solution for drug manufacturers, allowing
a digital scan of a drug to confirm its authenticity and reveal
provenance information such as manufacturing location, dosage,
images of packaging, expiration date, supply chain data, and lot or
batch number. WuXi and TruTag Technologies announced their
alliance in 2014, including an investment by the WuXi Venture Fund
in TruTag.
TruTags have a number of benefits for pharmaceutical
manufacturers that were confirmed in this joint testing:
- TruTags can be applied to qualifying solid oral dosage form
(SODF) products using a consistent, repeatable process.
- No new manufacturing equipment and changes in manufacturing
processes are needed.
- After application on manufactured tablets, TruTags are
successfully detected using TruTag's proprietary optical detection
device.
- Apart from this detection process, TruTags are covert and not
visually identifiable and remain with the tablet for its entire
life.
- Once applied, the TruTag solution did not affect the stability
or dissolution properties of API drugs in completed accelerated
open and closed bottle testing.
- Implementing the TruTag solution on existing drugs requires
minimal regulatory reporting changes for drug manufacturers and
complies with the physical-chemical identifier (PCID) guidance
issued by the U.S. Food and Drug Administration in 2011.
WuXi and TruTag will now begin further testing of TruTags on
additional API products. They will also produce a technical
white paper for the industry detailing the results of the
application method and practice, the detection process and data
collection, and outcomes of dissolution and stability
testing. TruTag is already working with several multinational
pharmaceutical companies in pilot testing for broad deployment of
this technology in marketed SODF drugs and product
candidates.
"We are very excited about these results," said Dr. Ge Li, Chairman and CEO of WuXi PharmaTech. "At
WuXi, we are always seeking cutting-edge solutions like TruTags to
help support the development and protection of our customers'
innovative products."
Kent Mansfield, President of
TruTag Technologies, commented, "We are excited to confirm these
results in testing conducted with our partner WuXi PharmaTech, an
innovative company that values its customers' IP and patients'
safety. We have demonstrated the ability of our technology to
integrate an edible and safe identification code directly into an
oral solid drug, thereby indelibly marking the product with an
internal code for its lifetime. In the near term, this will allow
drug manufacturers and distributors to have the ultimate audit of a
drug's provenance and origin without reliance on packaging or
laboratory chemical analysis."
"One can think of TruTags as a form of edible PIATS, or Product
Identification Authentication Tracking System, which can be
embedded into a product like unique fingerprints," said
Hank Wuh, MD, MPH, TruTag
Technologies' Founder and Chairman. "With our ability to securely
identify individual goods without labels or packaging, we aim to
dramatically improve the safety and traceability of critical
products such as food and medicine and in the process to have a
fundamental impact on big data."
About WuXi PharmaTech:
WuXi PharmaTech (NYSE: WX) is a
leading open-access R&D capability and technology platform
company serving the pharmaceutical, biotechnology, and medical
device industries, with operations in China and the United
States. As a research-driven and customer-focused
company, WuXi PharmaTech provides pharmaceutical, biotechnology and
medical device companies with a broad and integrated portfolio of
laboratory and manufacturing services throughout the drug and
medical device R&D process. WuXi is also building a
platform to provide clinical diagnostic services directly to
physicians and their patients globally. WuXi PharmaTech's
services are designed to help its global partners in shortening the
cycle and lowering the cost of drug and medical device
R&D. The operating subsidiaries of WuXi PharmaTech are
known as WuXi AppTec.
About TruTag Technologies:
TruTag Technologies is the
developer of a leading edible, covert security platform to address
the trillion-dollar global illicit product challenge and the
$200 billion market for counterfeit
drugs. TruTags® are edible, dust-sized particles embedded with
spectral data into the very fabric of a product, much like
fingerprints on a person, without the need for labels or
packaging. TruTag's covert, low–cost, heat–resistant, and
edible silica microtags serve as bar codes and can be incorporated
into solid, oral-dose medications as well as other materials and
products. The unique physical properties of TruTags® provide a vast
library of available unique codes, which allow for tracking of
high-volume, high-value items at product or even batch
levels. This business information tool can be used in a
variety of products, such as pharmaceuticals, nutritional
supplements, food, electronics, industrial components, consumer
goods, and medical devices.
The TruTag® security platform provides superior brand
protection, enhances the safety and traceability of food and
medicine, improves tracking and logistics, assures product quality,
optimizes efficiency in clinical trial administration, provides
informatics for product and component tracking through the supply
chain, and enables the Internet of Things. TruTag
Technologies, Inc., is a 2014 Technology Pioneer as selected by the
World Economic Forum, an honor awarded to the world's most
innovative and influential companies whose technology can
significantly impact the way business and society
operates. Learn more at www.TruTags.com.
TRUTAG and TRUTAGS are registered trademarks of
TruTag Technologies, Inc.
Contact:
TruTag Technologies, Inc.
Paula Page
paula@paulapagepr.com,
650.279.3881
WuXi PharmaTech
Ronald Aldridge (for investors)
LaVoieHealthScience
raldridge@lavoiehealthscience.com
617.374.8800 x109
Aaron Shi (for the media)
Director, Corporate Communications
pr@wuxiapptec.com
+86.21.5046.4362
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/wuxi-pharmatech-and-trutag-technologies-complete-successful-testing-of-edible-on-dose-authentication-solution-for-pharmaceuticals-300125815.html
SOURCE WuXi PharmaTech